Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
osimertinib (tagrisso) (1 trial)
pravastatin (pravachol) (1 trial)
ppmx-t003 (1 trial)
Stroke (Phase 3)
Trials (3 total)
Trial APIs (3 total)